Concepedia

Laurens van Houdt

LV

5

Publications

227

Citations

5

H-Index

2016

Active since

Affiliations

Radboud University Nijmegen(Current)

Radboud University Medical Center

Institute of Cancer Research

Royal Marsden NHS Foundation Trust

Dermatopathologie Friedrichshafen

Laurens van Houdt is an author at Radboud University Nijmegen specializing in tumor biology, tumor microenvironment, and extracellular matrix.

Top concepts

Publications per year

2016–2020

5

Publications

5

Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8+ lymphocytes in primary sarcomas is subtype dependent

Anke van Erp, Yvonne M.H. Versleijen‐Jonkers, Melissa H.S. Hillebrandt-Roeffen et al. · Oncotarget · 2017 · 95 citations · Full text

Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib

Anke van Erp, Melissa H.S. Hillebrandt-Roeffen, Laurens van Houdt et al. · Targeted Oncology · 2017 · 39 citations · Full text

Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes

Emmy D.G. Fleuren, Myrella Vlenterie, Winette T.A. van der Graaf et al. · Cancer Research · 2017 · 35 citations · Full text

Targeting the extracellular matrix of ovarian cancer using functionalized, drug loaded lyophilisomes

Sophieke C.H.A. van der Steen, René Raavé, Sjoerd Langerak et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2016 · 31 citations · Full text

, , +15

Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo

Anke van Erp, Laurens van Houdt, Melissa H.S. Hillebrandt-Roeffen et al. · Journal of Cancer Research and Clinical Oncology · 2020 · 27 citations · Full text

Rows per page

1–5 of 5